Evidence map›Paper›PMID 24695699›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Specification of spatial identities of cerebellar neuron progenitors by ptf1a and atoh1 for proper production of GABAergic and glutamatergic neurons.

Mayumi Yamada, Yusuke Seto, Shinichiro Taya, Tomoo Owa, Yukiko U Inoue, Takayoshi Inoue, Yoshiya Kawaguchi, Yo-Ichi Nabeshima, Mikio Hoshino

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Cerebellar development after preterm birth.Frontiers in cell and developmental biology · 2022
    Review
  18. Review
  19. Article
  20. Diagnostic Approach to Cerebellar Hypoplasia.Cerebellum (London, England) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Mayumi YamadaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan, Integrative Bioscience and Biomedical Engineering, Faculty of Science and Engineering, Waseda University, Tokyo 169-8555, Japan, School of Biomedical Science and Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan, Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan, and Laboratory of Molecular Life Science, Foundation for Biomedical Research and Innovation, Kobe 650-0047, Japan.
Yusuke Seto
Shinichiro Taya
Tomoo Owa
Yukiko U Inoue
Takayoshi Inoue
Yoshiya Kawaguchi
Yo-Ichi Nabeshima
Mikio Hoshino
National Center of Neurology and Psychiatry · JPFoundation for Biomedical Research and Innovation · JPKyoto University · JPTokyo Medical and Dental University · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the cerebellum, the bHLH transcription factors Ptf1a and Atoh1 are expressed in distinct neuroepithelial regions, the ventricular zone (VZ) and the rhombic lip (RL), and are required for producing GABAergic and glutamatergic neurons, respectively. However, it is unclear whether Ptf1a or Atoh1 is sufficient for specifying GABAergic or glutamatergic neuronal fates. To test this, we generated two novel knock-in mouse lines, Ptf1a(Atoh1) and Atoh1(Ptf1a), that are designed to express Atoh1 and Ptf1a ectopically in the VZ and RL, respectively. In Ptf1a(Atoh1) embryos, ectopically Atoh1-expressing VZ cells produced glutamatergic neurons, including granule cells and deep cerebellar nuclei neurons. Correspondingly, in Atoh1(Ptf1a) animals, ectopically Ptf1a-expressing RL cells produced GABAergic populations, such as Purkinje cells and GABAergic interneurons. Consistent results were also obtained from in utero electroporation of Ptf1a or Atoh1 into embryonic cerebella, suggesting that Ptf1a and Atoh1 are essential and sufficient for GABAergic versus glutamatergic specification in the neuroepithelium. Furthermore, birthdating analyses with BrdU in the knock-in mice or with electroporation studies showed that ectopically produced fate-changed neuronal types were generated at temporal schedules closely simulating those of the wild-type RL and VZ, suggesting that the VZ and RL share common temporal information. Observations of knock-in brains as well as electroporated brains revealed that Ptf1a and Atoh1 mutually negatively regulate their expression, probably contributing to formation of non-overlapping neuroepithelial domains. These findings suggest that Ptf1a and Atoh1 specify spatial identities of cerebellar neuron progenitors in the neuroepithelium, leading to appropriate production of GABAergic and glutamatergic neurons, respectively.

Indexed as

Age FactorsAnimalsAnimals, NewbornBasic Helix-Loop-Helix ProteinsCell DifferentiationCerebellumEmbryo, Mammaliangamma-Aminobutyric AcidGene Expression Regulation, DevelopmentalGlutamic AcidKi-67 AntigenMiceMice, Inbred C57BLMice, TransgenicMutationNeural Stem CellsAtoh1 protein, mouseBasic Helix-Loop-Helix Proteinsgamma-Aminobutyric AcidGlutamic AcidKi-67 Antigentranscription factor PTF1Transcription Factorscerebellumdevelopmentidentityneuronspatialtranscription factor

Identifiers

PMID24695699
PMCPMC6802724
OpenAlexW1984330992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.